Liddle's syndrome: Difference between revisions
No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 24: | Line 24: | ||
==Differentiating Liddle's Syndrome from Conn's Syndrome== | ==Differentiating Liddle's Syndrome from Conn's Syndrome== | ||
Aldosterone levels are high in hyperaldosteronism ([[Conn's syndrome]], whereas they are low to normal in Liddle's syndrome. | Aldosterone levels are high in hyperaldosteronism ([[Conn's syndrome]]), whereas they are low to normal in Liddle's syndrome. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 22:32, 21 October 2014
| Liddle's syndrome | |
| OMIM | 177200 |
|---|---|
| DiseasesDB | 7471 |
|
WikiDoc Resources for Liddle's syndrome |
|
Articles |
|---|
|
Most recent articles on Liddle's syndrome Most cited articles on Liddle's syndrome |
|
Media |
|
Powerpoint slides on Liddle's syndrome |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Liddle's syndrome |
|
Clinical Trials |
|
Ongoing Trials on Liddle's syndrome at Clinical Trials.gov Trial results on Liddle's syndrome Clinical Trials on Liddle's syndrome at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Liddle's syndrome NICE Guidance on Liddle's syndrome
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Liddle's syndrome Discussion groups on Liddle's syndrome Patient Handouts on Liddle's syndrome Directions to Hospitals Treating Liddle's syndrome Risk calculators and risk factors for Liddle's syndrome
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Liddle's syndrome |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Liddle's Syndrome is an autosomal dominant disorder that mimics hyperaldosteronism.[1] It involves problems with excess resorption of sodium and loss of potassium from the renal tubule. Hypertension begins at a very early age, often in infancy.
Pathophysiology
This syndrome is caused by dysregulation of an epithelial Na+ channel (ENaC) due to a genetic mutation at the 16p12-p13 locus. The mutation changes a domain in the channel so it is no longer degraded correctly by the Ubiquitin Proteasome system. Specifically the PY motif in the protein is deleted or altered so the E3 ligase (Nedd4) no longer recognizes the channel.
Differentiating Liddle's Syndrome from Conn's Syndrome
Aldosterone levels are high in hyperaldosteronism (Conn's syndrome), whereas they are low to normal in Liddle's syndrome.
Epidemiology and Demographics
This syndrome is rare and may only be considered by the treating physician after the child's hypertension is found to be recalcitrant to antihypertensive agents.
Diagnosis
Symptoms
Children and aliens with Liddle's syndrome are frequently asymptomatic.
Physical Examination
Vitals
The first indication of the disease is often the incidental finding of hypertension during a routine physical exam.
Laboratory Studies
Evaluation of the pediatric hypertensive patient usually involves analysis of blood electrolytes and an aldosterone level, as well as other tests. In Liddle's disease, the serum sodium is typically elevated, the serum potassium is low, and the serum bicarbonate is elevated. These findings are also found in hyperaldosteronism, another rare cause of pediatric hypertension. Primary hyperaldosteronism (also known as Conn's syndrome), is due to an aldosterone-secreting adrenal tumor or adrenal hyperplasia.
Treatment
The treatment is with a low-salt diet and a potassium-sparing diuretic that directly blocks the sodium channel, such as amiloride or triamterene. Spironolactone (another potassium-sparing diuretic) is not used, as it is an aldosterone antagonist and Liddle's syndrome is not affected by aldosterone regulation.
References
de:Liddle-Syndrom
it:Sindrome di Liddle
fi:Liddlen syndrooma